Holen Sie sich die Stockscreener-App
206.15
0.87%
1.8288
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$204.32
Offen:
$202.96
24-Stunden-Volumen:
1.20M
Relative Volume:
0.49
Marktkapitalisierung:
$48.99B
Einnahmen:
$234.31B
Nettoeinkommen (Verlust:
$1.61B
KGV:
31.12
EPS:
6.6243
Netto-Cashflow:
$4.45B
1W Leistung:
+4.10%
1M Leistung:
+33.56%
6M Leistung:
+39.01%
1J Leistung:
+64.45%
1-Tages-Spanne:
$201.59
$206.30
1-Wochen-Bereich:
$197.19
$207.47
52-Wochen-Spanne:
$114.60
$207.47
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Vergleichen Sie CAH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
206.21 | 48.55B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
MCK
Mckesson Corporation
|
847.23 | 103.77B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
364.41 | 70.46B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
HSIC
Henry Schein Inc
|
73.17 | 8.58B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.47 | 829.29M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Why Cardinal Health Inc. (CLH) stock could be next leaderEarnings Growth Summary & Stock Portfolio Risk Control - newser.com
Can Cardinal Health Inc. stock hit consensus price targets2025 Price Action Summary & Real-Time Price Movement Reports - newser.com
There's Been No Shortage Of Growth Recently For Cardinal Health's (NYSE:CAH) Returns On Capital - Yahoo Finance
Can Cardinal Health Inc. stock sustain institutional flowsJuly 2025 PreEarnings & Accurate Intraday Trade Tips - newser.com
Is Cardinal Health Inc. stock a top dividend aristocrat candidateQuarterly Risk Review & Free Expert Approved Momentum Trade Ideas - newser.com
CAH (Cardinal Health) Total Operating Expense : $6,060 Mil (TTM As of Sep. 2025) - GuruFocus
Day 5 of Gains Streak for Cardinal Health Stock with 8% Return (vs. 76% YTD) [11/10/2025] - Trefis
Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice - Yahoo Finance
How Cardinal Health Inc. stock valuation compares with sectorJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
Will Cardinal Health Inc. (CLH) stock outperform Dow JonesJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - newser.com
Is Cardinal Health Inc. stock testing key supportTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
When is the best time to exit Cardinal Health Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com
Tools to monitor Cardinal Health Inc. recovery probabilityMarket Rally & Risk Managed Investment Strategies - newser.com
Cardinal Health Shares Sink on Mixed Results, $1.9 Billion Solaris Health Deal - MSN
Why millennials buy Cardinal Health Inc. (CLH) stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Understanding Cardinal Health Inc.’s price movementJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com
Trend analysis for Cardinal Health Inc. this weekJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
Cardinal Health (CAH): A Closer Look at Valuation Following Robust Share Price Gains - Yahoo Finance
Cardinal Health's (NYSE:CAH) Dividend Will Be $0.5107 - simplywall.st
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo! Finance Canada
Do Cardinal Health's (NYSE:CAH) Earnings Warrant Your Attention? - Yahoo Finance
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term - sharewise.com
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health stock hits all-time high at 201.56 USD By Investing.com - Investing.com Nigeria
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
What Cardinal Health (CAH)'s Strong Q1 Earnings and Dividend Hike Mean for Shareholders - Sahm
Real time social sentiment graph for Cardinal Health Inc.2025 Stock Rankings & Consistent Profit Alerts - newser.com
Cardinal Health Elects Board, Approves Executive Compensation - TipRanks
[Form 4] CARDINAL HEALTH INC Insider Trading Activity - Stock Titan
[8-K] CARDINAL HEALTH INC Reports Material Event | CAH SEC FilingForm 8-K - Stock Titan
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH) - Yahoo Finance
Is Cardinal Health Inc. stock vulnerable to regulatory risksJuly 2025 PostEarnings & Pattern Based Trade Signal System - newser.com
Cardinal Health surges as it raises FY 2026 EPS guidance - MSN
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Cardinal Health Stock: Analyst Estimates & Ratings - MSN
Can Cardinal Health Inc. recover in the next quarterJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
Using R and stats models for Cardinal Health Inc. forecastingCEO Change & Low Risk High Win Rate Stock Picks - newser.com
Will Cardinal Health Inc. stock see insider buyingJuly 2025 Final Week & Community Consensus Stock Picks - newser.com
2 Reasons to Watch CAH and 1 to Stay Cautious - The Globe and Mail
The 5 Most Interesting Analyst Questions From Cardinal Health’s Q3 Earnings Call - The Globe and Mail
Volatility clustering patterns for Cardinal Health Inc.2025 Trading Volume Trends & Risk Managed Trade Strategies - newser.com
Why Cardinal Health Inc. stock appeals to analysts2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Cardinal Health raises 2026 EPS guidance to $9.65–$9.85 amid strong double-digit segment growth and Solaris Health acquisition - MSN
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Does Cardinal Health Inc. show high probability of reboundProfit Target & Risk Managed Investment Strategies - newser.com
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
2.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):